BHLHE41 and cervical cancer: We quantified cell viability of HeLa, SiHa and another apoptosis-sensitive cervical cancer cell, Caski, by combination treatment of DEC1 or DEC2 overexpression and cisplatin (Figure 3A bottom panel).